In stable kidney transplant patients, the extent of reactivity is inversely correlated with the amount of ongoing immunosuppression. [27] Again, validation of this assay in larger, more diverse ...

Anusha Gupta, the leading scientist in the development of the Ciliary Beat Frequency (CBF) assay, has played an instrumental role in advancing research on the small airway epithelium cell model ...

There has been little innovation in immunosuppression therapy for organ transplant patients over the past 30 years. The standard of care immunosuppressive drugs used post-transplant have been ...

Commercial assays for simultaneous genotyping and detection of E6/E7 mRNA from the five most common high-risk HPV types are now available and require further evaluation for primary screening ...

As this won’t be used in the initial phase 1/2 trial, patients will have to receive immunosuppressive drugs to dampen down the immune response. Working much like an organ transplant, this could ...

About 33% of ocular tuberculosis patients may relapse within 2 years of achieving clinical inactivity, with a poor initial ...

Although the follow up drilling campaign - looking for extensions down plunge and along strike - has now been wrapped up for the winter season, the latest assay results have yielded significant ...

dThe David Price Evans Global Health & Infectious Diseases Group, The University of Liverpool, Liverpool, UK eThe African Centre of Excellence in Bioinformatics and Data Intensive Sciences, The ...